Anxiety disorders are a group of psychiatric conditions characterized by excessive fear, worry, and physiological hyperarousal that cause clinically significant distress or impairment. Clinically, the hallmark is persistent or recurrent anxiety that is disproportionate to actual circumstances and difficult to control. Patients may present with cognitive symptoms (e.g., persistent “future-focused” worry, rumination, catastrophizing), behavioral symptoms (avoidance, reassurance seeking, safety behaviors), and somatic manifestations (palpitations, shortness of breath, tremor, gastrointestinal discomfort). Although transient anxiety is a normal adaptive response, anxiety disorders become disorders when they are chronic, pervasive, and interfere with functioning.
Neurobiologically, anxiety is mediated by coordinated activity within cortico–striato–thalamo–cortical circuits and limbic networks, particularly the amygdala, hippocampus, and prefrontal cortex. The amygdala detects threat cues and signals heightened salience, while the prefrontal cortex normally regulates fear responses through top-down control. In anxiety disorders, this regulatory circuitry is often inefficient, leading to exaggerated threat appraisal. Neurotransmitter systems contribute to symptom expression: dysregulation of serotonergic signaling affects fear inhibition and mood regulation; noradrenergic systems influence arousal and vigilance; and GABAergic inhibitory pathways are commonly implicated in heightened reactivity. Stress physiology is also relevant: chronic hyperactivation of the hypothalamic–pituitary–adrenal (HPA) axis can sustain cortisol-related changes in threat processing and stress reactivity.
Diagnostic evaluation requires careful differential diagnosis. Anxiety disorders can mimic or be mimicked by medical conditions such as hyperthyroidism, cardiac arrhythmias, pheochromocytoma, and medication or substance-induced states (including stimulant use and caffeine excess). Clinicians also distinguish anxiety disorders from depressive disorders, obsessive-compulsive and related disorders, trauma- and stressor-related disorders, and psychotic disorders. Diagnostic criteria typically specify duration (often at least several months depending on the disorder), symptom clusters, and degree of impairment. Screening tools (e.g., GAD-7, GADQ-IV, PHQ-9 for comorbidity) can support initial assessment but do not replace diagnostic judgment.
Common anxiety disorders include generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and specific phobias. In GAD, excessive anxiety and worry occur more days than not and are associated with symptoms such as restlessness, fatigue, difficulty concentrating, irritability, and sleep disturbance. Panic disorder involves recurrent unexpected panic attacks alongside worry about additional attacks or behavioral change to avoid them. Social anxiety disorder centers on fear of negative evaluation and avoidance of social or performance situations. Specific phobias involve marked fear and avoidance of specific stimuli, with anxiety out of proportion to actual threat.
Psychological mechanisms provide clinically useful models. Cognitive behavioral theory proposes that catastrophic interpretations of bodily sensations and ambiguous cues amplify anxiety, while avoidance prevents disconfirmation of feared outcomes. Exposure-based therapies target these maintaining mechanisms by habituating fear responses and updating threat beliefs through corrective learning. In GAD, interventions often address intolerance of uncertainty and worry scheduling, reducing cognitive perpetuation cycles. For panic disorder, interoceptive exposure helps patients reinterpret catastrophic misinterpretations of normal physiologic sensations (e.g., palpitations, dizziness).
Evidence-based treatments are typically multimodal. First-line psychotherapy for several anxiety disorders is cognitive behavioral therapy (CBT), including exposure techniques and cognitive restructuring. For GAD, CBT frequently incorporates worry monitoring, cognitive restructuring, and behavioral experiments. Pharmacotherapy can be considered for moderate to severe symptoms, comorbidities, or when rapid symptom relief is needed. Selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs) are commonly used due to favorable long-term efficacy and safety profiles relative to older agents. Benzodiazepines may provide short-term relief for acute anxiety but are generally not preferred as long-term treatment due to risks such as sedation, cognitive impairment, dependence, and withdrawal.
Clinical management also emphasizes lifestyle and risk reduction: adequate sleep, limiting caffeine and other stimulants, regular physical activity, and structured stress management can reduce physiologic arousal and improve coping. For patients with significant impairment, integrated care addressing comorbid depression, substance use, and medical contributors improves outcomes.
In summary, anxiety disorders reflect maladaptive threat processing and impaired regulation across neurocognitive circuits, reinforced by cognitive and behavioral maintaining factors. Accurate diagnosis requires attention to medical mimics and differential psychiatric conditions. Effective care commonly combines evidence-based psychotherapy—especially CBT and exposure-based approaches—with pharmacotherapy such as SSRIs/SNRIs when indicated, alongside targeted self-management strategies. Source: @theobserver
The Charlotte Observer: Inside the Global Street Food Scene That Pushed Michelin to Finally Recognize Hawkers and Taquerías. #breaking
— @theobserver May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
